Article
TGA approves Epidyolex, developed by GW Pharma, the second registered medicinal cannabis product
This is the second medicinal cannabis product to have been approved by the TGA, since Emerge Health's Sativex in 2012.
Pearce IP


Showing 1–20 of 53 results